News
MFA Financial (NYSE:MFA) reported second-quarter 2026 results marked by stable book value, portfolio growth and accelerated resolution of delinquent loans, while realized credit losses continued to weigh on distributable earnings.
Chief Executive Officer Craig Knutson said the company delivered a 2
Via MarketBeat · August 8, 2026
An above-average COLA could really pay off for these beneficiaries.
Via The Motley Fool · August 8, 2026
Magnera (NYSE:MAGN) reported third-quarter fiscal 2026 revenue of $857 million and adjusted EBITDA of $99 million, its strongest earnings quarter since the company was formed, according to management. Adjusted EBITDA increased 9% from the prior-year quarter, supported by merger synergies, Project CO
Via MarketBeat · August 8, 2026
Louisiana-Pacific (NYSE:LPX) reported lower second-quarter sales and EBITDA as weak oriented strand board, or OSB, pricing weighed on results, while its Siding segment remained profitable and the company said it expects that business to return to year-over-year growth in the third quarter.
Net sale
Via MarketBeat · August 8, 2026
James Hardie Industries (NYSE:JHX) reported first-quarter results above its original guidance, supported by stronger-than-expected organic growth in fiber cement products, commercial execution and continued integration progress following its AZEK acquisition.
Total net sales rose 64% on a reported
Via MarketBeat · August 8, 2026
Uma's disposition represents a 17% reduction in his total equity holdings following a year in which the stock delivered a 34% return.
Via The Motley Fool · August 8, 2026
Headwinds are mounting for a scorching-hot bull market.
Via The Motley Fool · August 8, 2026
Hamilton Insurance Group (NYSE:HG) reported second-quarter net income of $144 million, or $1.42 per diluted share, as catastrophe losses tied primarily to the Middle East conflict weighed on underwriting results. The insurer recorded an annualized return on average equity of 21% and operating income
Via MarketBeat · August 8, 2026
A weekly roundup of MarketBeat analysis covering earnings from AbbVie, AMD, Palantir, Meta, Reddit, SpaceX and others, plus upcoming CPI and PPI inflation data.
Via MarketBeat · August 8, 2026
Social Security's "Trump bump" and the president's flagship "Big, Beautiful Bill" are doing a number on America's leading retirement program.
Via The Motley Fool · August 8, 2026
Guardian Pharmacy Services (NYSE:GRDN) reported second-quarter revenue growth of 2% year over year to $351.2 million, while adjusted EBITDA increased 19% to $29.7 million, as the company said it continued to offset profitability pressure from Inflation Reduction Act-related drug pricing reductions.
Via MarketBeat · August 8, 2026
Genie Energy (NYSE:GNE) reported higher second-quarter profitability as normalized wholesale energy market conditions restored margins at its retail energy business, while its growth segment reached positive EBITDA.
For the three months ended June 30, 2026, consolidated revenue declined 4.6% year o
Via MarketBeat · August 8, 2026
It's not just smaller benefits you have to think about.
Via The Motley Fool · August 8, 2026
President Donald Trump's policies, coupled with Wall Street's hottest trend, are a dangerous recipe for stocks.
Via The Motley Fool · August 8, 2026
Off Grid Solar Street Light Market, valued at a robust USD 4.26 billion in 2024, is on a trajectory of significant expansion, projected to reach approximat
Via Talk Markets · August 8, 2026
Traveling to an unfamiliar destination offers an exciting way to take a break, experience different cultures, and recharge your energy. However, showing up
Via Talk Markets · August 8, 2026
Enovis (NYSE:ENOV) reported second-quarter 2026 sales of $583 million, up 3% on a reported basis and 5% organically, as growth in its Reconstruction business offset a slower but still expanding Performance & Recovery segment. Management said the company’s results reflected improved commercial ex
Via MarketBeat · August 8, 2026
Trump is again weighing Federal Reserve Governor Lisa Cook’s removal, reviving a legal battle over allegations she disputes.
Via Benzinga · August 8, 2026
Emergent Biosolutions (NYSE:EBS) reported second-quarter 2026 revenue and adjusted EBITDA above its prior guidance and analyst consensus, driven by accelerated medical countermeasure deliveries to U.S. government customers. The company also lowered its full-year outlook as increased competition and
Via MarketBeat · August 8, 2026
Cooper-Standard (NYSE:CPS) reported higher second-quarter sales but lower adjusted EBITDA as material inflation, tariffs and other cost pressures outweighed operational savings. Management said it expects commercial recoveries and continued cost actions to improve results in the second half while ma
Via MarketBeat · August 7, 2026
Operating profit jumped 14% on margin expansion and cost discipline.
Via The Motley Fool · August 7, 2026
Newell returns to sales growth for first time in four years, raising full-year guidance.
Via The Motley Fool · August 7, 2026
Record net income drove 27.9% return on equity, beating industry average.
Via The Motley Fool · August 7, 2026
Net cash position surged to $991 million as gold prices climbed.
Via The Motley Fool · August 7, 2026
Organic sales grew 5.8% on volume gains and market share expansion across core brands.
Via The Motley Fool · August 7, 2026
